130 related articles for article (PubMed ID: 26340458)
1. Central venous access device insertion and perioperative management of patients with severe haemophilia A: a local experience.
Fonseca A; Nagel K; Decker K; Pukulakatt M; Pai M; Walton M; Chan AK
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):156-9. PubMed ID: 26340458
[TBL] [Abstract][Full Text] [Related]
2. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
[TBL] [Abstract][Full Text] [Related]
3. Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial.
van Moort I; Preijers T; Bukkems LH; Hazendonk HCAM; van der Bom JG; Laros-van Gorkom BAP; Beckers EAM; Nieuwenhuizen L; van der Meer FJM; Ypma P; Coppens M; Fijnvandraat K; Schutgens REG; Meijer K; Leebeek FWG; Mathôt RAA; Cnossen MH;
Lancet Haematol; 2021 Jul; 8(7):e492-e502. PubMed ID: 34171280
[TBL] [Abstract][Full Text] [Related]
4. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of BAY 81-8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme.
Oldenburg J; Windyga J; Hampton K; Lalezari S; Tseneklidou-Stoeter D; Beckmann H; Maas Enriquez M
Haemophilia; 2016 May; 22(3):349-53. PubMed ID: 26931631
[TBL] [Abstract][Full Text] [Related]
6. Perioperative haemostasis in children with haemophilia and inhibitors during central venous catheter surgery: The Karolinska model.
Hägglöf H; Magnusson M; Petrini P; Frisk T; Ranta S
Haemophilia; 2018 Sep; 24(5):e380-e383. PubMed ID: 30088320
[No Abstract] [Full Text] [Related]
7. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI.
Viswabandya A; Mathews V; George B; Nair SC; Baidya S; Mammen JJ; Chandy M; Srivastava A
Haemophilia; 2008 Jul; 14(4):763-7. PubMed ID: 18445014
[TBL] [Abstract][Full Text] [Related]
8. Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.
Neunert CE; Miller KL; Journeycake JM; Buchanan GR
Haemophilia; 2008 Mar; 14(2):260-70. PubMed ID: 18179577
[TBL] [Abstract][Full Text] [Related]
9. Difficult clinical challenges in haemophilia: international experiential perspectives.
Forsyth AL; Giangrande P; Hay CR; Kenet G; Kessler CM; Knöbl PN; Llinás A; Santagostino E; Young G
Haemophilia; 2012 Jul; 18 Suppl 5():39-45. PubMed ID: 22757683
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of Nuwiq
Zozulya N; Kessler CM; Klukowska A; von Depka M; Hampton K; Hay CRM; Jansen M; Bichler J; Knaub S; Rangarajan S
Haemophilia; 2018 Jan; 24(1):70-76. PubMed ID: 29048712
[TBL] [Abstract][Full Text] [Related]
11. Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator.
McCarthy CE; O'Brien M; Andrews J; Zoland JM; Macasiray E; Wong W; Lo C; Glader B; Tamaresis J; Jeng M
Haemophilia; 2016 Jan; 22(1):81-6. PubMed ID: 26248602
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland.
Vepsäläinen K; Lassila R; Arola M; Huttunen P; Koskinen S; Ljung R; Lähteenmäki P; Möttönen M; Riikonen P
Haemophilia; 2016 Sep; 22(5):721-9. PubMed ID: 27339837
[TBL] [Abstract][Full Text] [Related]
13. Break-through bleeding in relation to pharmacokinetics of Factor VIII in paediatric patients with severe haemophilia A.
Cheng X; Li P; Chen Z; Zhang N; Zhen Y; Zhao L; Wang X; Wu R
Haemophilia; 2018 Jan; 24(1):120-125. PubMed ID: 29194866
[TBL] [Abstract][Full Text] [Related]
14. Current dosing practices for perioperative factor VIII concentrate treatment in mild haemophilia A patients result in FVIII levels above target.
Schütte LM; de Rooij N; Hazendonk HCAM; Mathôt RAA; van Hest RM; Leebeek FWG; Cnossen MH; Kruip MJHA
Haemophilia; 2019 Nov; 25(6):960-968. PubMed ID: 31487098
[TBL] [Abstract][Full Text] [Related]
15. How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access.
Nijdam A; Kurnik K; Liesner R; Ljung R; Nolan B; Petrini P; Fischer K;
Haemophilia; 2015 Jul; 21(4):444-50. PubMed ID: 25582494
[TBL] [Abstract][Full Text] [Related]
16. Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study.
Rothschild C; D'Oiron R; Borel-Derlon A; Gruel Y; Navarro R; Negrier C
Haemophilia; 2013 Mar; 19(2):281-6. PubMed ID: 23038998
[TBL] [Abstract][Full Text] [Related]
17. The "OPTI-CLOT" trial. A randomised controlled trial on periOperative PharmacokineTIc-guided dosing of CLOTting factor concentrate in haemophilia A.
Hazendonk HC; van Moort I; Fijnvandraat K; Kruip MJ; Laros-van Gorkom BA; van der Meer FJ; Meijer K; Peters M; Schutgens RE; Zwaan CM; Driessens MH; Polinder S; Leebeek FW; Mathôt RA; Cnossen MH
Thromb Haemost; 2015 Aug; 114(3):639-44. PubMed ID: 26062822
[TBL] [Abstract][Full Text] [Related]
18. Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland.
Vepsäläinen K; Lassila R; Arola M; Lähteenmäki P; Möttönen M; Mäkipernaa A; Riikonen P
Haemophilia; 2015 Nov; 21(6):747-53. PubMed ID: 25832453
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of differences in annual factor VIII utilization among haemophilia A patients.
Epstein J; Xiong Y; Woo P; Li-McLeod J; Spotts G
Haemophilia; 2012 Mar; 18(2):187-92. PubMed ID: 21883704
[TBL] [Abstract][Full Text] [Related]
20. Central venous access device-related infections in patients with haemophilia.
Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
